Dynamic & INST Metabolic Flux Analysis - Creative Proteomics Metabolomics

Q: How many time points are needed for an INST‑MFA study?

A defensible INST‑MFA study typically requires 4 to 8 distinct sampling time points spanning the period from initial tracer introduction to near‑plateau enrichment. Sampling frequency is concentrated in the early kinetic phase when isotopic enrichment changes most rapidly.

Q: What is the difference between INST‑MFA and steady‑state 13C‑MFA?

Steady‑state 13C‑MFA measures a single endpoint after isotopic equilibrium has been reached, assuming constant pool sizes and constant fluxes. INST‑MFA models the transient rate of isotopic enrichment across multiple time points, enabling flux quantification in slow‑labeling or autotrophic systems before isotopic equilibrium is attained.

Q: How do you ensure sampling speed is fast enough for transient flux analysis?

We utilize automated fast‑filtration or sub‑second cryogenic quenching in pre‑chilled organic solvent baths (−80 °C) to arrest intracellular enzymatic interconversion instantly at each designated time point.

Q: What statistical metrics validate the fitted dynamic flux models?

Models are evaluated using Chi‑square goodness‑of‑fit criteria, parameter sensitivity analysis, and profile likelihood estimation to compute rigorous 95% confidence intervals for all estimated flux parameters.

Why Dynamic and INST Metabolic Flux Analysis Matters

Conventional isotope-based metabolic flux analysis is most informative when a biological system and its isotope labeling have both reached a stable state. Many important studies do not meet that condition: cells may be adapting to a nutrient switch, responding to a perturbation, progressing through a fed-batch phase, or accumulating label slowly in large metabolic pools. Dynamic and isotopically nonstationary metabolic flux analysis (INST-MFA) recover pathway information from the trajectory of isotope incorporation rather than waiting for a single endpoint measurement.

Our metabolic flux analysis service can be extended to time-resolved studies when the central question is not only where carbon is routed, but when that routing changes. We design the experiment around biologically meaningful sampling windows, tracer atom transitions, and the model constraints needed to distinguish true flux changes from dilution, pool-size effects, or incomplete enrichment.

INST-MFA or Dynamic MFA: Selecting the Correct Modeling Framework

Study condition	Recommended framework	What is estimated
Cell growth and extracellular rates are approximately constant during labeling, but intracellular label enrichment is evolving	INST-MFA	Constant intracellular fluxes, reversible exchange fluxes, and—where supported by the data—metabolite pool sizes
Substrate uptake, secretion, biomass formation, metabolite pools, or pathway activity change over the experimental window	Dynamic MFA	Time-varying flux profiles and concentration-dependent pathway behavior across defined phases
A short pulse experiment is intended to identify early label propagation or pathway ordering	Tracer kinetic profiling or reduced dynamic model	Relative pathway activity, labeling kinetics, and evidence for model refinement before full flux estimation

INST-MFA does not remove every steady-state assumption. It is appropriate when metabolic fluxes and pool sizes can reasonably be treated as stable over the labeling window while isotopic enrichment is transient. Dynamic MFA is used when the biological state itself changes and time-dependent flux functions must be fitted. We document this distinction during feasibility review so that a transient-labeling data set is not overinterpreted as a dynamic-flux result.

Why Choose Creative Proteomics for Time-Resolved Fluxomics

Study design begins with identifiability.
We map the question, tracer positions, accessible metabolites, expected enrichment speed, and available time points before selecting a network. This prevents collecting an elegant time course that cannot constrain the intended branch point.
Sampling is treated as an analytical variable.
For transient labeling, a delay of seconds can alter the earliest isotopologue measurements. Our workflow plans culture replication, staggered collection, quenching sequence, and extraction batches together rather than treating sample preparation as a downstream task.
Model assumptions are made visible.
We specify compartment treatment, biomass and exchange constraints, tracer purity, natural-abundance correction, pool-size handling, and any excluded reactions. Residual patterns and confidence intervals are reviewed with the fitted flux map.
Outputs are built for interpretation.
You receive time-course enrichment tables, model-versus-measurement comparison plots, estimated parameter tables with statistical limits, and publication-ready vector figures illustrating pathway fluxes over time.

Tracer Strategies for Nonstationary and Dynamic Studies

Tracer configuration	Typical application	Transient readout
[U-¹³C₆]Glucose step feed	Glycolysis, PPP, and early TCA cycle entry	M+3 triose and pyruvate accumulation versus delayed M+2 or M+4 TCA cycle labeling
[1,2-¹³C₂]Glucose pulse	Glycolytic vs. oxidative PPP routing	Early appearance of M+1 vs. M+2 downstream intermediates before secondary label scrambling occurs
[U-¹³C₅,¹⁵N₂]Glutamine pulse	Anaplerosis, transamination, and reductive cycling	Coupled carbon and nitrogen entry into α-ketoglutarate, glutamate, aspartate, and citrate
Parallel position-labeled tracer scheme	Resolving network reversibility and exchange fluxes	Complementary label propagation rates across parallel cultures modeled with a joint network formulation

End-to-End Dynamic & INST-MFA Workflow

Feasibility Review & Network Formulation

We define the metabolic question, expected time scale, accessible metabolites, and network equations to confirm that the planned time points can constrain the desired fluxes.

Tracer Administration & Time-Course Sampling

Tracer addition is coordinated with dense, timed sampling. Replicate cultures are collected across early, intermediate, and late labeling windows to record label accumulation.

Sub-Second Quenching & Extraction

Fast low-temperature quenching halts enzymatic activity. Extraction conditions are matched to polar intermediates, organic acids, or amino acids to preserve labeling integrity.

High-Resolution Mass Spectrometry

Isotopologue envelopes (M+0 to M+n) are measured across target intermediates; chromatographic separation, peak integration, and natural-abundance corrections are documented.

Model Fitting & Residual Review

Ordinary differential equations or EMU-based nonstationary formulations are fitted to the time-resolved MID data. Residual patterns and goodness-of-fit are evaluated.

Flux Interpretation and Data Package

Results are delivered as pathway-centered flux maps, trajectory plots, model documentation, and structured source tables supported by our fluxomics data analysis service.

Six-step workflow for dynamic and isotopically nonstationary metabolic flux analysis

Sample Collection & Quenching Considerations

Sample Type	Typical Guidance	Harvest and Quenching Principles	Storage and Shipping
Adherent cell cultures	≥ 1–3 × 10⁶ cells per time point, typically 4–8 time points across 3 biological replicates	Rapid medium removal, immediate cold solvent addition on dry ice/ice, fast scraping. Avoid room-temperature wash steps.	Store at −80 °C; ship on dry ice
Suspension cells	≥ 2–5 × 10⁶ cells per time point across planned sampling schedule	Fast filtration or direct cold quenching into pre-chilled solvent; separate biomass and supernatant quickly to arrest pool turnover.	Store at −80 °C; ship on dry ice
Bioreactor & fermentation samples	Biomass volume determined by cell density and target intermediate concentrations	Rapid sampling device or syringe-based cold quenching directly into cold methanol/acetonitrile mixture; minimize harvest transit time.	Store at −80 °C; ship on dry ice
Conditioned culture medium	≥ 200 µL per time point, matched to cellular sampling times	Clarify by fast centrifugation at 4 °C; collect supernatants across time course to measure external uptake and secretion rates.	Store at −80 °C; ship on dry ice

Research Applications of Time-Resolved Fluxomics

Transient response to drug treatment: Track metabolic redirection within minutes to hours following kinase inhibition, metabolic enzyme targeting, or pathway rescue.
Nutrient adaptation & media transition: Measure how cells switch between carbon sources during diauxic shifts, glucose depletion, or amino acid restriction.
Photosynthetic & autotrophic metabolism: Quantify carbon fixation and assimilate partitioning in microalgae or cyanobacteria where steady-state labeling is slow to achieve.
Bioprocess phase transitions: Model shifting carbon yields and byproduct accumulation across exponential, transition, and stationary production phases.

What You Receive: Data & Documentation Package

Time-course isotopologue data matrix: Annotated, natural-abundance-corrected M+0 through M+n values for all target intermediates across every sampling time point (.csv / Excel).
External boundary rate tables: Measured or fitted time-dependent uptake and secretion rates used as boundary conditions.
Model definition & equations: Complete stoichiometric reaction list, carbon-atom transition mapping, compartment definitions, and configuration files.
Fitted flux & parameter summary: Estimated pathway flux values, reversible exchange parameters, and associated statistical confidence intervals.
Residual diagnostics & fit plots: Time-course measurement-versus-model trajectory curves and residual distribution analysis.
Publication-ready figures: Vector-format metabolic pathway flux maps with time-resolved or phase-specific flux annotations.

Time-course mass isotopomer distributions and ODE model-fit trajectories

Time-course mass isotopomer distribution (MID) plots showing experimental enrichment data overlaid with fitted nonstationary model trajectories across early and late sampling windows.

Dynamic metabolic flux map showing time-varying reaction rates and parameter confidence intervals

Publication-oriented dynamic metabolic flux map illustrating time-dependent flux redistribution, phase-specific pathway throughput, and parameter confidence limits.

Case Study: Dynamic Glucose Flux Redirection in Compensatory Cardiac Hypertrophy

Background: Pressure overload induces cardiac hypertrophy, during which cardiomyocytes undergo dramatic metabolic remodeling. While static metabolomics reveals altered intermediate levels, whether these changes represent altered glycolytic velocity or altered downstream oxidation requires time-resolved stable-isotope tracing in vivo.

Experimental Setup: Mice subjected to transverse aortic constriction (TAC) or sham surgery were infused with [U-¹³C₆]glucose. Ventricular tissue was collected at defined time points following tracer infusion, rapidly quenched, and analyzed by high-resolution LC-MS/MS and GC-MS to measure mass isotopologue enrichment in glycolytic and TCA cycle intermediates.

Metabolomics and 13C-glucose stable isotope tracing of cardiac metabolic reprogramming

Figure 2. Dynamic ¹³C-glucose incorporation into glycolytic and TCA cycle intermediates in pressure-overload hypertrophic myocardium vs. sham controls.

Key Findings: Time-course ¹³C-enrichment revealed that pressure overload selectively accelerates the early flux of glucose through hexokinase and phosphofructokinase into pyruvate and lactate, while uncoupling glycolytic throughput from mitochondrial pyruvate oxidation. Concurrently, tracer incorporation into the hexosamine biosynthetic pathway and de novo serine synthesis was elevated, supporting compensatory myocardial growth.

Schematic model of YAP-mediated metabolic reprogramming and glycolytic flux redirection

Figure 13. Mechanistic model demonstrating transcriptional regulation of rate-limiting glycolytic flux enzymes driving cardiac remodeling under biomechanical stress.

Reference: The Journal of Clinical Investigation, 2022, 132(6): e150595. DOI: 10.1172/JCI150595

How many time points are needed for an INST-MFA study?

A defensible INST-MFA study typically requires 4 to 8 distinct sampling time points spanning the period from initial tracer introduction to near-plateau enrichment. Sampling frequency is concentrated in the early kinetic phase when isotopic enrichment changes most rapidly.

What is the difference between INST-MFA and steady-state ¹³C-MFA?

Steady-state ¹³C-MFA measures a single endpoint after isotopic equilibrium has been reached, assuming constant pool sizes and constant fluxes. INST-MFA models the transient rate of isotopic enrichment across multiple time points, enabling flux quantification in slow-labeling or autotrophic systems before isotopic equilibrium is attained.

Can INST-MFA estimate intracellular metabolite pool sizes?

Yes. Because the rate of isotope accumulation depends both on reaction flux and the physical size of the intermediate pool, nonstationary model fitting can estimate active intracellular pool sizes when supported by adequate temporal data density.

How do you ensure sampling speed is fast enough for transient flux analysis?

We utilize automated fast-filtration or sub-second cryogenic quenching in pre-chilled organic solvent baths (−80 °C) to arrest intracellular enzymatic interconversion instantly at each designated time point.

What statistical metrics validate the fitted dynamic flux models?

Models are evaluated using Chi-square goodness-of-fit criteria, parameter sensitivity analysis, and profile likelihood estimation to compute rigorous 95% confidence intervals for all estimated flux parameters.

Representative Publications Utilizing Time-Resolved & INST Fluxomics

Kashyap S., et al. Isotopically nonstationary ¹³C metabolic flux analysis of cyanobacterial metabolism. Frontiers in Microbiology, 2021, 12: 673905.
Young J.D. INCA: a computational platform for isotopically non-stationary metabolic flux analysis. Bioinformatics, 2014, 30(9): 1333-1335.
Noh K., et al. ¹³C flux spectral analysis: a generic approach for isotopically non-stationary metabolic flux analysis. Metabolic Engineering, 2007, 9(5-6): 468-483.